Our study adds to this notion, by analyzing the cellular effects of Fingolimod in two X-linked neurodevelopmental disorders, namely Rett syndrome (RTT) and Cdkl5 deficiency disorder (CDD). This evidence concerns the gene CDKL5 and atypical Rett syndrome.